Under pressure: Cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy

Annual Review of Neuroscience

Volumn 35, Issue , 2012, Pages 153-179

  Nickells, Robert W ^a   Howell, Gareth R ^b   Soto, Ileana ^b   John, Simon W M ^b,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Astrocytes; Glia; Ocular hypertension; Optic nerve head; Retinal ganglion cells

Indexed keywords

ASTROCYTE; CELLULAR STRESS RESPONSE; DISEASE ASSOCIATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; LAMINA PROPRIA; MICROGLIA; MONOCYTE; NERVE DEGENERATION; NERVE FIBER; NERVE INJURY; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; RETINA GANGLION CELL; REVIEW; SIGNAL TRANSDUCTION; SOMATIC CELL;

ANIMALS; AXONS; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GLAUCOMA; INFLAMMATION; INTRAOCULAR PRESSURE; NERVE DEGENERATION; OPTIC DISK; RETINAL GANGLION CELLS; SIGNAL TRANSDUCTION; WALLERIAN DEGENERATION;

EID: 84862640900     PISSN: 0147006X     EISSN: 15454126     Source Type: Book Series    
DOI: 10.1146/annurev.neuro.051508.135728     Document Type: Review

References (186)

1. Abe N, Cavalli V. 2008. Nerve injury signaling. Curr. Opin. Neurobiol. 18:276-83
2. Abu-Amero KK, Morales J, Bosley TM. 2006. Mitochondrial abnormalities in patients with primary openangle glaucoma. Invest. Ophthalmol. Vis. Sci. 47:2533-41 (Pubitemid 351639838)
3. Almasieh M, Zhou Y, Kelly ME, Casanova C, Di Polo A. 2011. Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors. Cell Death Dis. 1:e27
4. Anderson DR. 1996. Glaucoma, capillaries and pericytes. 1. Blood flow regulation. Ophthalmologica 210:257-62 (Pubitemid 26276076)
5. Anderson DR. 1999. Introductory comments on blood flow autoregulation in the optic nerve head and vascular risk factors in glaucoma. Surv. Ophthalmol. 43(Suppl. 1):S5-S9 (Pubitemid 29328574)
6. Anderson DR, Hendrickson A. 1974. Effect of intraocular pressure on rapid axoplasmic transport in monkey optic nerve. Invest. Ophthalmol. 13:771-83
7. Anderson DR, Libby RT, Gould DB, Smith RS, John SWM. 2005. High-dose radiation with bone marrow transfer prevents neurodegeneration in an inherited glaucoma. Proc. Natl. Acad. Sci. USA 102(12):4566-71 (Pubitemid 40397152)
8. Anderson DR, Quigley HA. 1992. The optic nerve. In Adler's Physiology of the Eye, ed. WMHart Jr, pp. 616-40. St. Louis, MO: Mosby Year Book
9. Araki T, Sasaki Y, Milbrandt J. 2004. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305:1010-13 (Pubitemid 39071777)
10. Babetto E, Beirowski B, Janeckova L, Brown R, Gilley J, et al. 2010. Targeting NMNAT1 to axons and synapses transforms its neuroprotective potency in vivo. J. Neurosci. 30:13291-304
11. Bae C, Sachs F, Gottlieb PA. 2011. The mechanosensitive ion channel Piezo 1 is inhibited by the peptide GsMTx4. Biochemistry 50:6295-300
12. Baltan S, Inman DM, Danilov CA, Morrison RS, Calkins DJ, Horner PJ. 2010. Metabolic vulnerability disposes retinal ganglion cell axons to dysfunction in a model of glaucomatous degeneration. J. Neurosci. 30:5644-52
13. Barrientos SA, Martinez NW, Yoo S, Jara JS, Zamorano S, et al. 2011. Axonal degeneration is mediated by the mitochondrial permeability transition pore. J. Neurosci. 31:966-78
14. Barron MJ, Griffiths P, Turnbull DM, Bates D, Nichols P. 2004. The distributions of mitochondria and sodium channels reflect the specific energy requirements and conduction properties of the human optic nerve head. Br. J. Ophthalmol. 88:286-90 (Pubitemid 38142105)
15. Beirowski B, Babetto E, Coleman MP, Martin KR. 2008. The WldS gene delays axonal but not somatic degeneration in a rat glaucoma model. Eur. J. Neuro. 28:1166-79
16. Bellezza AJ, Rintalan CJ, Thompson HW, Downs JC, Hart RT, Burgoyne CF. 2003. Deformation of the lamina cribrosa and anterior scleral canal wall in early experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 44:623-37 (Pubitemid 36159708)
17. Berdahl JP, Allingham RR, Johnson DH. 2008. Cerebrospinal fluid pressure is decreased in primary openangle glaucoma. Ophthalmology 115:763-68 (Pubitemid 351602306)
18. Bortner CD, Cidlowski JA. 2007. Cell shrinkage and monovalent cation fluxes: role in apoptosis. Arch. Biochem. Biophys. 462:176-88 (Pubitemid 46863418)
19. Bosco A, Inman DM, Steele MR, Wu G, Soto I, et al. 2008. Reduced retinal microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. Invest. Ophthalmol. Vis. Sci. 49:1437-46
20. Brambilla R, Bracchi-Ricard V, Hu WH, Frydel B, Bramwell A, et al. 2005. Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J. Exp. Med. 202:145-56 (Pubitemid 41002917)
21. Brown AM, Ransom BR. 2007. Astrocyte glycogen and brain energy metabolism. Glia 55:1263-71 (Pubitemid 47235367)
22. Buckingham BP, Inman DM, Lambert W, Oglesby E, Calkins DJ, et al. 2008. Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J. Neurosci. 28:2735-44 (Pubitemid 351398885)
23. Burgoyne CF. 2010. A biomechanical paradigm for axonal insult within the optic nerve head in aging and glaucoma. Exp. Eye Res. 93:120-32
24. Burgoyne CF, Downs JC, Bellezza AJ, Hart RT. 2004. Three-dimensional reconstruction of normal and early glaucoma monkey optic nerve head connective tissues. Invest. Ophthalmol. Vis. Sci. 45:4388-99 (Pubitemid 39564664)
25. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, et al. 2008. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci. 28:264-78
26. Cavalli V, Kujala P, Klumperman J, Goldstein LS. 2005. Sunday Driver links axonal transport to damage signaling. J. Cell Biol. 168:775-87 (Pubitemid 40328161)
27. Chauhan BC, Pan J, Archibald ML, LeVatte TL, Kelly ME, Tremblay F. 2002. Effect of intraocular pressure on optic disc topography, electrophysiology, and axonal loss in a chronic pressure-induced rat model of optic nerve damage. Invest. Ophthalmol. Vis. Sci. 43:2969-76 (Pubitemid 34977047)
28. Cheng L, Sapieha P, Kittlerova P, Hauswirth WW, Di Polo A. 2002. TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo. J. Neurosci. 22:3977-86 (Pubitemid 37465706)
29. Chidlow G, Ebneter A, Wood JP, Casson RJ. 2011. The optic nerve head is the site of axonal transport disruption, axonal cytoskeleton damage and putative axonal regeneration failure in a rat model of glaucoma. Acta Neuropathol. 121:737-51
30. Chiquet M. 1999. Regulation of extracellular matrix gene expression by mechanical stress. Matrix Biol. 18:417-26
31. Chung KK, David KK. 2010. Emerging roles of nitric oxide in neurodegeneration. Nitric Oxide 22:290-95
32. CNTGSG. 1998. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patientswith therapeutically reduced intraocular pressures. CollaborativeNormal-Tension Glaucoma Study Group. Am. J. Ophthalmol. 126:487-97
33. Cohen-Cory S, Escand́on E, Fraser SE. 1996. The cellular patterns of BDNF and trkB expression suggest multiple roles for BDNF during Xenopus visual system development. Dev. Biol. 179:102-15 (Pubitemid 26363250)
34. Cohen-Cory S, Fraser SE. 1994. BDNF in the development of the visual system of Xenopus. Neuron 12:747-61 (Pubitemid 24126236)
35. Coleman MP, Freeman MR. 2010. Wallerian degeneration, Wld S, andNmnat. Annu. Rev. Neurosci. 33:245-67
36. Crish SD, Sappington RM, Inman DM, Horner PJ, Calkins DJ. 2010. Distal axonopathy with structural persistence in glaucomatous neurodegeneration. Proc. Natl. Acad. Sci. USA 107:5196-201
37. Crooks KR, Allingham RR, Qin X, Liu Y, Gibson JR, et al. 2011. Genome-wide linkage scan for primary open angle glaucoma: influences of ancestry and age at diagnosis. PLoS One 6:e21967
38. Czeh M, Gressens P, Kaindl AM. 2011. The yin and yang of microglia. Dev. Neurosci. 33:199-209
39. Dandona L, Hendrickson A, Quigley HA. 1991. Selective effects of experimental glaucoma on axonal transport by retinal ganglion cells to the dorsal lateral geniculate nucleus. Invest. Ophthalmol. Vis. Sci. 32:484-91
40. Danias J, Lee KC, Zamora MF, Chen B, Shen F, et al. 2003. Quantitative analysis of retinal ganglion cell (RGC) loss in aging DBA/2NNia glaucomatous mice: comparison with RGC loss in aging C57/BL6 mice. Invest. Ophthalmol. Vis. Sci. 44:5151-62 (Pubitemid 37475383)
41. Deckwerth TL, Johnson EM Jr. 1994. Neurites can remain viable after destruction of the neuronal soma by programmed cell death (apoptosis). Dev. Biol. 165:63-72 (Pubitemid 24306102)
42. Del Zoppo GJ, Milner R, Mabuchi T, Hung S, Wang X, Koziol JA. 2006. Vascular matrix adhesion and the blood-brain barrier. Biochem. Soc. Trans. 34:1261-66 (Pubitemid 46769034)
43. Di Polo A, Aigner LJ, Dunn RJ, Bray GM, Aguayo AJ. 1998. Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected M̈uller cells temporarily rescues injured retinal ganglion cells. Proc. Natl. Acad. Sci. USA 95:3978-83
44. DiNuzzo M, Mangia S, Maraviglia B, Giove F. 2010. Changes in glucose uptake rather than lactate shuttle take center stage in subserving neuroenergetics: evidence from mathematical modeling. J. Cereb. Blood Flow Metab. 30:586-602
45. Downs JC, Roberts MD, Sigal IA. 2011. Glaucomatous cupping of the lamina cribrosa: a review of the evidence for active progressive remodeling as a mechanism. Exp. Eye Res. 93:133-40
46. Dvoriantchikova G, Barakat D, Brambilla R, Agudelo C, Hernandez E, et al. 2009. Inactivation of astroglial NF-kappa B promotes survival of retinal neurons following ischemic injury. Eur. J. Neurosci. 30:175-85
47. Ebneter A, Casson RJ, Wood JP, Chidlow G. 2010. Microglial activation in the visual pathway in experimental glaucoma: spatiotemporal characterization and correlation with axonal injury. Invest. Ophthalmol. Vis. Sci. 51:6448-60
48. Ethier CR. 2006. Scleral biomechanics and glaucoma: a connection? Can. J. Ophthalmol. 41:9-12, 4
49. Farina C, Aloisi F, Meinl E. 2007. Astrocytes are active players in cerebral innate immunity. Trends Immunol. 28:138-45 (Pubitemid 46283692)
50. Fernandes KA, Harder JM, Fornarola LB, Freeman RS, Clark AF, et al. 2012. JNK2 and JNK3 are major regulators of axonal injury-induced retinal ganglion cell death. Neurobiol. Dis. In press
51. Filippopoulos T, Danias J, Chen B, Podos SM, Mittag TW. 2006. Topographic and morphologic analyses of retinal ganglion cell loss in old DBA/2NNia mice. Invest. Ophthalmol. Vis. Sci. 47:1968-74 (Pubitemid 46768277)
52. Gaasterland D, Tanishima T, Kuwabara T. 1978. Axoplasmic flow during chronic experimental glaucoma I. Light and electron microscopic studies of the monkey optic nerve head during development of glaucomatous cupping. Invest. Ophthalmol. Vis. Sci. 17:838-46 (Pubitemid 8389865)
53. Grau V, Downs JC, Burgoyne CF. 2006. Segmentation of trabeculated structures using an anisotropicMarkov random field: application to the study of the optic nerve head in glaucoma. IEEE Trans. Med. Imaging 25(3):245-55 (Pubitemid 43320642)
54. Grieshaber MC, Mozaffarieh M, Flammer J. 2007. What is the link between vascular dysregulation and glaucoma? Surv. Ophthalmol. 52(Suppl. 2):S144-54 (Pubitemid 350060966)
55. Harwerth RS, Carter-Dawson L, Shen F, Smith EL III, Crawford LV. 1999. Ganglion cell losses underlying visual field defects from experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 40:2242-50 (Pubitemid 29418378)
56. Harwerth RS, Crawford ML, Frishman LJ, Viswanathan S, Smith EL III, Carter-Dawson L. 2002. Visual field defects and neuronal losses from experimental glaucoma. Prog. Retin. Eye Res. 21:91-125 (Pubitemid 34242709)
57. He S, Prasanna G, Yorio T. 2007. Endothelin-1-mediated signaling in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in astrocytes. Invest. Ophthalmol. Vis. Sci. 48:3737-45 (Pubitemid 351261112)
58. Hernandez MR, Igoe F, Neufeld AH. 1988. Cell culture of the human lamina cribrosa. Invest. Ophthalmol. Vis. Sci. 29:78-89 (Pubitemid 18038774)
59. Herrmann JE, Imura T, Song B, Qi J, Ao Y, et al. 2008. STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J. Neurosci. 28:7231-43
60. Howell GR, Libby RT, Jakobs TC, Smith RS, Phalan FC, et al. 2007. Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma. J. Cell Biol. 179:1523-37
61. Howell GR, Libby RT, John SW. 2008. Mouse genetic models: an ideal system for understanding glaucomatous neurodegeneration and neuroprotection. Prog. Brain Res. 173:303-21
62. Howell GR, Macalinao DG, Sousa GL, Walden M, Soto I, et al. 2011a. Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma. J. Clin. Invest. 121:1429-44
63. Howell GR, Soto I, Zhu X, Ryan M, Macalinao DG, et al. 2012. Radiation treatment inhibits monocyte entry into the optic nerve head and prevents neuronal damage in a mouse model of glaucoma. J. Clin. Invest. 122:1246-61
64. Howell GR, Walton DO, King BL, Libby RT, John SWM. 2011b. Datgan, a reusable software system for facile interrogation and visualization of complex transcription profiling data. BMC Genomics 12:429
65. Huang W, Fileta J, Guo Y, Grosskreutz CL. 2006. Downregulation of Thy1 in retinal ganglion cells in experimental glaucoma. Curr. Eye Res. 31:265-71 (Pubitemid 43379197)
66. Jakobs TC, Libby RT, Ben Y, JohnSWM, MaslandRH. 2005. Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. J. Cell Biol. 171:313-25 (Pubitemid 41540023)
67. Johnson EC, Doser TA, Cepurna WA, Dyck JA, Jia L, et al. 2011. Cell proliferation and interleukin-6-type cytokine signaling are implicated by gene expression responses in early optic nerve head injury in rat glaucoma. Invest. Ophthalmol. Vis. Sci. 52:504-18
68. Johnson EC, Guo Y, Cepurna WO, Morrison JC. 2009. Neurotrophin roles in retinal ganglion cell survival: Lessons from rat glaucoma models. Exp. Eye Res. 88:808-15
69. Johnson EC, Jia L, Cepurna WA, Doser TA, Morrison JC. 2007. Global changes in optic nerve head gene expression after exposure to elevated intraocular pressure in a rat glaucoma model. Invest. Ophthalmol. Vis. Sci. 48:3161-77 (Pubitemid 351261161)
70. Johnson EC, Morrison JC. 2009. Friend or foe? Resolving the impact of glial responses in glaucoma. J. Glaucoma 18:341-53
71. Johnson EC, Morrison JC, Farrell S, Deppmeier L, Moore CG, McGintyMR. 1996. The effect of chronically elevated intraocular pressure on the rat optic nerve head extracellular matrix. Exp. Eye Res. 62:663-74 (Pubitemid 26201533)
72. Jonas JB. 2011. Role of cerebrospinal fluid pressure in the pathogenesis of glaucoma. Acta Ophthalmol. 89:505-14
73. Ju WK, Kim KY, Lindsey JD, Angert M, Duong-Polk KX, et al. 2008. Intraocular pressure elevation induces mitochondrial fission and triggers OPA1 release in glaucomatous optic nerve. Invest. Ophthalmol. Vis. Sci. 49:4903-11
74. Kanamori A, Catrinescu MM, Kanamori N, Mears KA, Beaubien R, Levin LA. 2010a. Superoxide is an associated signal for apoptosis in axonal injury. Brain 133:2612-25
75. Kanamori A, Catrinescu MM, Mahammed A, Gross Z, Levin LA. 2010b. Neuroprotection against superoxide anion radical by metallocorroles in cellular and murine models of optic neuropathy. J. Neurochem. 114:488-98
76. Kikuchi M, Tenneti L, Lipton SA. 2000. Role of p38 mitogen-activated protein kinase in axotomy-induced apoptosis of rat retinal ganglion cells. J. Neurosci. 20:5037-44 (Pubitemid 30421707)
77. Kimelberg HK, Nedergaard M. 2011. Functions of astrocytes and their potential as therapeutic targets. Neurotherapeutics 7:338-53
78. Koeberle PD, Wang Y, Schlichter LC. 2010. Kv1. 1 and Kv1. 3 channels contribute to the degeneration of retinal ganglion cells after optic nerve transection in vivo. Cell Death Differ. 17:134-44
79. Kompass KS, Agapova OA, Li W, Kaufman PL, Rasmussen CA, Hernandez MR. 2008. Bioinformatic and statistical analysis of the optic nerve head in a primate model of ocular hypertension. BMC Neurosci. 9:93
80. Kuehn MH, Kim CY, Jiang B, Dumitrescu AV, Kwon YH. 2008. Disruption of the complement cascade delays retinal ganglion cell death following retinal ischemia-reperfusion. Exp. Eye Res. 87:89-95
81. Kuehn MH, Kim CY, Ostojic J, Bellin M, Alward WL, et al. 2006. Retinal synthesis and deposition of complement components induced by ocular hypertension. Exp. Eye Res. 83:620-28 (Pubitemid 43902783)
82. Ladoux B, Anon E, Lambert M, Rabodzey A, Hersen P, et al. 2010. Strength dependence of cadherin-mediated adhesions. Biophys. J. 98:534-42
83. Lasker/IRRF. 2010. Astrocytes and glaucomatous neurodegeneration. http://www. laskerfoundation. org/programs/irrf. htm
84. Leon S, Yin Y, Nguyen J, Irwin N, Benowitz LI. 2000. Lens injury stimulates axon regeneration in the mature rat optic nerve. J. Neurosci. 20:4615-26 (Pubitemid 30396627)
85. Levy NS. 1974. The effects of elevated intraocular pressure on slow axonal protein flow. Invest. Ophthalmol. Vis. Sci. 13:691-95
86. Libby RT, Howell GR, Pang I-H, Savinova OV, Mehalow AK, et al. 2007. Inducible nitric oxide synthase, Nos2, does not mediate optic neuropathy and retinopathy in the DBA/2J glaucoma model. BMC Neurosci. 8:108
87. Libby RT, Li Y, Savinova OV, Barter J, Smith RS, et al. 2005. Susceptibility to neurodegeneration in glaucoma is modified by Bax gene dosage. PLoS Genet. 1:17-26
88. Liu B, Neufeld AH. 2000. Expression of nitric oxide synthase-2 (NOS-2) in reactive astrocytes of the human glaucomatous optic nerve head. Glia 30:178-86 (Pubitemid 30199431)
89. Liu M, Duggan J, Salt TE, Cordeiro MF. 2011. Dendritic changes in visual pathways in glaucoma and other neurodegenerative conditions. Exp. Eye Res. 92:244-50
90. Lukas TJ, Wang AL, Yuan M, Neufeld AH. 2009. Early cellular signaling responses to axonal injury. Cell Commun. Signal. 7:5
91. Mabuchi F, Aihara M, Mackey MR, Lindsey JD, Weinreb RN. 2004. Regional optic nerve damage in experimental mouse glaucoma. Invest. Ophthalmol. Vis. Sci. 45:4352-58 (Pubitemid 39564660)
92. Mansour-Robaey S, Clarke DB, Wang Y-C, Bray GM, Aguayo AJ. 1994. Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc. Natl. Acad. Sci. USA 91:1632-36 (Pubitemid 24080259)
93. Martin KR, Quigley HA, Valenta D, Kielczewski J, Pease ME. 2006. Optic nerve dynein motor protein distribution changes with intraocular pressure elevation in a rat model of glaucoma. Exp. Eye Res. 83:255-62 (Pubitemid 43870221)
94. May CA, L̈utjen-Drecoll E. 2002. Morphology of themurine optic nerve. Invest. Ophthalmol. Vis. Sci. 43:2206-12
95. McKinnon SJ. 2003. Glaucoma: ocular Alzheimer's disease? Front. Biosci. 8:s1140-56 (Pubitemid 38925375)
96. McKinnon SJ, Schlamp CL, Nickells RW. 2009. Mouse models of retinal ganglion cell death and glaucoma. Exp. Eye Res. 88:816-24
97. Miller BR, Press C, Daniels RW, Sasaki Y, Milbrandt J, DiAntonio A. 2009. A dual leucine kinase-dependent axon self-destruction program promotes Wallerian degeneration. Nat. Neurosci. 12:387-89
98. Minckler DS, Bunt AH, Johanson GW. 1977. Orthograde and retrograde axoplasmic transport during acute ocular hypertension in the monkey. Invest. Ophthalmol. Vis. Sci. 16:426-41 (Pubitemid 8108644)
99. Morfini G, Pigino G, Szebenyi G, You Y, Pollema S, Brady ST. 2006. JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport. Nat. Neurosci. 9:907-16 (Pubitemid 43980505)
100. Morgan JE. 2002. Retinal ganglion cell shrinkage in glaucoma. J. Glaucoma 11:365-70 (Pubitemid 34832873)
101. Morgan JE. 2004. Circulation and axonal transport in the optic nerve. Eye (Lond. ) 18:1089-95 (Pubitemid 39591791)
102. Morgan JE, Uchida H, Caprioli J. 2000. Retinal ganglion cell death in experimental glaucoma. Br. J. Ophthalmol. 84:303-10 (Pubitemid 30251688)
103. Morrison JC, Farrell SK, Johnson EC, Deppmeier LMH, Moore CG, Grossmann E. 1995. Structure and composition of the rodent lamina cribrosa. Exp. Eye Res. 60:127-35
104. Morrison JC, Johnson EC, Cepurna W, Jia L. 2005. Understanding mechanisms of pressure-induced optic nerve damage. Prog. Retin Eye Res. 24:217-40 (Pubitemid 40021787)
105. Munemasa Y, Kitaoka Y, Kuribayashi J, Ueno S. 2010. Modulation of mitochondria in the axon and soma of retinal ganglion cells in a rat glaucoma model. J. Neurochem. 115:1508-19
106. Murphy JA, Archibald ML, Chauhan BC. 2010. The role of endothelin-1 and its receptors in optic nerve head astrocyte proliferation. Br. J. Ophthalmol. 94:1233-38
107. Nakazawa T, Nakazawa C, Matsubara A, Noda K, Hisatomi T, et al. 2006. Tumor necrosis factor-αmediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J. Neurosci. 26:12633-41 (Pubitemid 44904557)
108. Neufeld AH. 1999. Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma. Arch. Ophthalmol. 117:1050-56 (Pubitemid 29372938)
109. Neufeld AH, Sawada A, Becker B. 1999. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc. Natl. Acad. Sci. USA 96:9944-48 (Pubitemid 29398837)
110. Nguyen JV, Soto I, Kim KY, Bushong EA, Oglesby E, et al. 2011. Myelination transition zone astrocytes are constitutively phagocytic and have synuclein dependent reactivity in glaucoma. Proc. Natl. Acad. Sci. USA 108:1176-81
111. Nikolaev A, McLaughlin T, O'Leary DD, Tessier-Lavigne M. 2009. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 457:981-89
112. Nikolaeva MA, Mukherjee B, Stys PK. 2005. Na+-dependent sources of intra-axonal Ca2+ release in rat optic nerve during in vitro chemical ischemia. J. Neurosci. 25:9960-67 (Pubitemid 41528034)
113. Nikolskaya T, Nikolsky Y, Serebryiskaya T, Zvereva S, Sviridov E, et al. 2009. Network analysis of human glaucomatous optic nerve head astrocytes. BMC Med. Genomics 2:24
114. Okada S, Nakamura M, Katoh H, Miyao T, Shimazaki T, et al. 2006. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat. Med. 12:829-34 (Pubitemid 44050074)
115. Ostrow LW, Suchyna TM, Sachs F. 2011. Stretch induced endothelin-1 secretion by adult rat astrocytes involves calcium influx via stretch-activated ion channels (SACs). Biochem. Biophys. Res. Commun. 410:81-86
116. Pal SK, Hartnett KA, Nerbonne JM, Levitan ES, Aizenman E. 2003. Mediation of neuronal apoptosis by Kv2. 1-encoded potassium channels. J. Neurosci. 23:4798-802 (Pubitemid 36793203)
117. Panagis L, Zhao X, Ge Y, Ren L, Mittag TW, Danias J. 2009. Gene expression changes in areas of focal loss of retinal ganglion cells (RGC) in the retina of DBA/2J mice. Invest. Ophthalmol. Vis. Sci. 51:2024-34
118. Pang I-H, Johnson EC, Jia L, Cepurna WA, Shepard AR, et al. 2005. Evaluation of inducible nitric oxide synthase in glaucomatous optic neuropathy and pressure-induced optic nerve damage. Invest. Ophthalmol. Vis. Sci. 46:1313-21 (Pubitemid 41685871)
119. Pang IH, Clark AF. 2007. Rodent models for glaucoma retinopathy and optic neuropathy. J. Glaucoma 16:483-505 (Pubitemid 47263052)
120. Pease ME, McKinnon SJ, Quigley HA, Kerrigan-Baumrind LA, Zack DJ. 2000. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 41:764-74 (Pubitemid 30158887)
121. Pelzel HR, Schlamp CL, Nickells RW. 2010. Histone H4 deacetylation plays a critical role in early gene silencing during neuronal apoptosis. BMC Neurosci. 11:62
122. Pelzel HR, Schlamp CL, Waclawski M, Shaw MK, Nickells W. 2012. Silencing of Fem1cR3 gene expression in the DBA/2J mouse precedes retinal ganglion cell death and is associated with histone deacetylase activity. Invest. Ophthalmol. Vis. Sci. 53:1428-35
123. Pena JD, Varela HJ, Ricard CS, HernandezMR. 1999. Enhanced tenascin expression associated with reactive astrocytes in human optic nerve heads with primary open angle glaucoma. Exp. Eye Res. 68:29-40 (Pubitemid 29084570)
124. Perlson E, Jeong GB, Ross JL, Dixit R, Wallace KE, et al. 2009. A switch in retrograde signaling from survival to stress in rapid-onset neurodegeneration. J. Neurosci. 29:9903-17
125. Perry VH, Nicoll JA, Holmes C. 2010. Microglia in neurodegenerative disease. Nat. Rev. Neurol. 6:193-201
126. Pinto LH, Klumpp DJ. 1998. Localization of potassium channels in the retina. Prog. Retin. Eye Res. 17:207-30 (Pubitemid 28339913)
127. Pournaras CJ, Rungger-Brandle E, Riva CE, Hardarson SH, Stefansson E. 2008. Regulation of retinal blood flow in health and disease. Prog. Retin Eye Res. 27:284-330
128. Prasanna G, Hulet C, Desai D, Krishnamoorthy RR, Narayan S, et al. 2005. Effect of elevated intraocular pressure on endothelin-1 in a rat model of glaucoma. Pharmacol. Res. 51:41-50 (Pubitemid 39425072)
129. Quigley HA. 1993. Open-angle glaucoma. New Engl. J. Med. 328:1097-106 (Pubitemid 23097800)
130. Quigley HA. 2011. Glaucoma. Lancet 377:1367-77
131. Quigley HA, Addicks EM. 1981. Regional differences in the structure of the lamina cribrosa and their relation to glaucomatous optic nerve damage. Arch. Ophthalmol. 99:137-43 (Pubitemid 11168786)
132. Quigley HA, Anderson DR. 1976. The dynamics and location of axonal transport blockage by acute intraocular pressure elevation in primate optic nerve. Invest. Ophthalmol. Vis. Sci. 15:606-16
133. Quigley HA, Broman AT. 2006. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 90:262-67 (Pubitemid 43325451)
134. Quigley HA, Cone FE, Gelman SE, Yang Z, Son JL, et al. 2011. Lack of neuroprotection against experimental glaucoma in c-Jun N-terminal kinase 3 knockout mice. Exp. Eye Res. 92:299-305
135. Quigley HA, Hohman RM, Addicks EM, Massof RW, Green WR. 1983. Morphologic changes in the lamina cribrosa correlated with neural loss in open-angle glaucoma. Am. J. Ophthalmol. 95(5):673-91 (Pubitemid 13092793)
136. Quigley HA, McKinnon SJ, Zack DJ, Pease ME, Kerrigan-Baumrind LA, et al. 2000. Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats. Invest. Ophthalmol. Vis. Sci. 41:3460-66
137. Radius RL, Anderson DR. 1981. Rapid axonal transport in primate optic nerve. Arch. Ophthalmol. 99:650-54
138. Ralay Ranaivo H, Zunich S, Choi N, Hodge J, Wainwright M. 2011. Mild stretch-induced injury increases susceptibility to interleukin-1beta-induced release of matrix metalloproteinase-9 from astrocytes. J. Neurotrauma 38:1757-66
139. Ransom B, Behar T, Nedergaard M. 2003. New roles for astrocytes (stars at last). Trends Neurosci. 26:520-22 (Pubitemid 37176905)
140. Rao VR, Krishnamoorthy RR, Yorio T. 2007. Endothelin-1, endothelin A and B receptor expression and their pharmacological properties in GFAP negative human lamina cribrosa cells. Exp. Eye Res. 84:1115-24 (Pubitemid 46770724)
141. Rao VR, Krishnamoorthy RR, Yorio T. 2008. Endothelin-1 mediated regulation of extracellular matrix collagens in cells of human lamina cribrosa. Exp. Eye Res. 86:886-94
142. Redman PT, He K, Hartnett KA, Jefferson BS, Hu L, et al. 2007. Apoptotic surge of potassium currents is mediated by p38 phosphorylation of Kv2. 1. Proc. Natl. Acad. Sci. USA 104:3568-73 (Pubitemid 46364199)
143. Roberts MD, Grau V, Grimm J, Reynaud J, Bellezza AJ, et al. 2009. Remodeling of the connective tissue microarchitecture of the lamina cribrosa in early experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 50:681-90
144. Roberts MD, Liang Y, Sigal IA, Grimm J, Reynaud J, et al. 2010. Correlation between local stress and strain and lamina cribrosa connective tissue volume fraction in normal monkey eyes. Invest. Ophthalmol. Vis. Sci. 51:295-307
145. Rodieck RW. 1998. The First Steps in Seeing. Sunderland, MA: Sinauer
146. Rodriguez-Enriquez S, He L, Lemasters JJ. 2004. Role of mitochondrial permeability transition pores in mitochondrial autophagy. Int. J. Biochem. Cell Biol. 36:2463-72 (Pubitemid 39119759)
147. Rosen AM, Stevens B. 2010. The role of the classical complement cascade in synapse loss during development and glaucoma. Adv. Exp. Med. Biol. 703:75-93
148. Ruiz-Ederra J, Garcia M, Hernandez M, Urcola H, Herńandez- Barb́achano E, et al. 2005. The pig eye as a novel model of glaucoma. Exp. Eye Res. 81:561-69 (Pubitemid 41532001)
149. Salinas-Navarro M, Alarcon-Martinez L, Valiente-Soriano FJ, Jimenez-LopezM, Mayor-Torroglosa S, et al. 2010. Ocular hypertension impairs optic nerve axonal transport leading to progressive retinal ganglion cell degeneration. Exp. Eye Res. 90:168-83
150. Sarasa-Renedo A, Chiquet M. 2005. Mechanical signals regulating extracellular matrix gene expression in fibroblasts. Scand. J. Med. Sci. Sports 15:223-30 (Pubitemid 41032386)
151. Sasaki Y, Vohra BP, Lund FE, Milbrandt J. 2009. Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide. J. Neurosci. 29:5525-35
152. Schlamp CL, Johnson EC, LiY, Morrison JC, NickellsRW. 2001. Changes inThy1 gene expression associated with damaged retinal ganglion cells. Mol. Vis. 7:192-201 (Pubitemid 36153670)
153. Schlamp CL, Li Y, Dietz JA, Janssen KT, Nickells RW. 2006. Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric. BMC Neurosci. 7:66
154. Schwartz M, London A. 2009. Immune maintenance in glaucoma: boosting the body's own neuroprotective potential. J. Ocul. Biol. Dis. Infor. 2:73-77
155. Semaan SJ, Li Y, Nickells RW. 2010. A single nucleotide polymorphism in the Bax gene promoter affects transcription and influences retinal ganglion cell death. ASN Neuro 2:e00032
156. Shareef S, Sawada A, Neufeld AH. 1999. Isoforms of nitric oxide synthase in the optic nerves of rat eyes with chronic moderately elevated intraocular pressure. Invest. Ophthalmol. Vis. Sci. 40:2884-91 (Pubitemid 29521601)
157. Shields MB. 1997. Textbook of Glaucoma. Baltimore, MA:Williams & Wilkins
158. Sigal IA, Ethier CR. 2009. Biomechanics of the optic nerve head. Exp. Eye Res. 88:799-807
159. Sigal IA, Flanagan JG, Ethier CR. 2005. Factors influencing optic nerve head biomechanics. Invest. Ophthalmol. Vis. Sci. 46:4189-99 (Pubitemid 44264622)
160. Sigal IA, Flanagan JG, Tertinegg I, Ethier CR. 2004. Finite element modeling of optic nerve head biomechanics. Invest. Ophthalmol. Vis. Sci. 45:4378-87 (Pubitemid 39564663)
161. Sofroniew MV. 2009. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 32:638-47
162. Sofroniew MV, Vinters HV. 2010. Astrocytes: biology and pathology. Acta Neuropathol. 119:7-35
163. Son JL, Soto I, Oglesby E, Lopez-Roca T, Pease ME, et al. 2010. Glaucomatous optic nerve injury involves early astrocyte reactivity and late oligodendrocyte loss. Glia 58:780-89
164. Soto I, Oglesby E, Buckingham BP, Son JL, Roberson EDO, et al. 2008. Retinal ganglion cells downregulate gene expression and lose their axons within the optic nerve head in a mouse glaucoma model. J. Neurosci. 28:548-61
165. Soto I, Pease ME, Son JL, Shi X, Quigley HA, Marsh-Armstrong N. 2011. Retinal ganglion cell loss in a rat ocular hypertension model is sectorial and involves early optic nerve axon loss. Invest. Ophthalmol. Vis. Sci. 52:434-41
166. Stasi K, Nagel D, Yang X, Wang RF, Ren L, et al. 2006. Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes. Invest. Ophthalmol. Vis. Sci. 47:1024-29 (Pubitemid 46768335)
167. Steele MR, InmanDM, Calkins DJ, Horner PJ, VetterML. 2006. Microarray analysis of retinal gene expression in the DBA/2J model of glaucoma. Invest. Ophthalmol. Vis. Sci. 47:977-85 (Pubitemid 46768330)
168. Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, et al. 2007. The classical complement cascade mediates CNS synapse elimination. Cell 131:1164-78 (Pubitemid 350235022)
169. Stirling DP, Stys PK. 2010. Mechanisms of axonal injury: internodal nanocomplexes and calcium deregulation. Trends Mol. Med. 16:160-70
170. Stys PK. 2005. General mechanisms of axonal damage and its prevention. J. Neurol. Sci. 233:3-13 (Pubitemid 40804810)
171. Suh SW, Bergher JP, AndersonCM, Treadway JL, Fosgerau K, SwansonRA. 2007. Astrocyte glycogen sustains neuronal activity during hypoglycemia: studies with the glycogen phosphorylase inhibitor CP-316, 819. J. Pharmacol. Exp. Ther. 321:45-50
172. Sun D, Lye-Barthel M, Masland RH, Jakobs TC. 2009. Themorphology and spatial arrangement of astrocytes in the optic nerve head of the mouse. J. Comp. Neurol. 516:1-19
173. Sun D, Lye-Barthel M, Masland RH, Jakobs TC. 2010. Structural remodeling of fibrous astrocytes after axonal injury. J. Neurosci. 30(42):14008-19
174. Taylor S, Calder CJ, Albon J, Erichsen JT, Boulton ME, Morgan JE. 2011. Involvement of the CD200 receptor complex in microglia activation in experimental glaucoma. Exp. Eye Res. 92:338-43
175. Tezel G, Yang X, Luo C, Peng Y, Sun SL, SunD. 2007. Mechanisms of immune system activation in glaucoma: oxidative stress-stimulated antigen presentation by the retina and optic nerve head glia. Invest. Ophthalmol. Vis. Sci. 48:705-14 (Pubitemid 351260704)
176. Wang AL, YuanM, Neufeld AH. 2006. Degeneration of neuronal cell bodies following axonal injury in WldS mice. J. Neurosci. Res. 84:1799-807 (Pubitemid 44892613)
177. Watson FL, Heerssen HM, Bhattacharyya A, Klesse L, Lin MZ, Segal RA. 2001. Neurotrophins use the Erk5 pathway to mediate a retrograde survival response. Nat. Neurosci. 4:981-88 (Pubitemid 32924137)
178. Wax MB, Tezel G. 2009. Immunoregulation of retinal ganglion cell fate in glaucoma. Exp. Eye Res. 88:825-30
179. Weber AJ, Harman CD, Viswanathan S. 2008. Effects of optic nerve injury, glaucoma, and neuroprotection on the survival, structure, and function of ganglion cells in the mammalian retina. J. Physiol. 586:4393-400
180. Weber AJ, Viswanathan S, Ramanathan C, Harman CD. 2010. Combined application of BDNFto the eye and brain enhances ganglion cell survival and function in the cat after optic nerve injury. Invest. Ophthalmol. Vis. Sci. 51:327-34
181. Whitmore AV, Libby RT, John SWM. 2005. Glaucoma: thinking in new ways: a role for autonomous axonal self-destruction and compartmentalised processes? Prog. Retin. Eye Res. 24:639-62 (Pubitemid 41254125)
182. Yamada M, Wong FL, Fujiwara S, Akahoshi M, SuzukiG. 2004. Noncancer disease incidence in atomic bomb survivors, 1958-1998. Radiat. Res. 161(6):622-32 (Pubitemid 39149570)
183. Yang Z, Quigley HA, Pease ME, Yang Y, Qian J, et al. 2007. Changes in gene expression in experimental glaucoma and optic nerve transection: the equilibrium between protective and detrimental mechanisms. Invest. Ophthalmol. Vis. Sci. 48:5539-48 (Pubitemid 351260855)
184. Yin Y, Henzl MT, Lorber B, Nakazawa T, Thomas TT, et al. 2006. Oncomodulin is a macrophage-derived signal for axon regeneration in retinal ganglion cells. Nat. Neurosci. 9:843-52
185. Yorio T, Krishnamoorthy R, Prasanna G. 2002. Endothelin: Is it a contributor to glaucoma pathophysiology? J. Glaucoma 11:259-70
186. Yu-Wai-Man P, Griffiths PG, Chinnery PF. 2011. Mitochondrial optic neuropathies: disease mechanisms and therapeutic strategies. Prog. Retin Eye Res. 30:81-114